Btx 1801 skin disease indication, page-3

my guess was 'golden staph', based on the data so far showing cbd kills msra (gram positive), and that 60% of staph infections in US hospitals are cause by msra. it's clearly a big health issue, but I haven't been able to find data that demonstrates revenue potential, so can't be sure if it's commercially attractive enough. guess we will find out soon. regardless of their first target, cbd is proving to be an incredibly versatile active compound, so lots of potential for additional product lines down the track.